首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to those using whole injectable antibiotics
【24h】

Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to those using whole injectable antibiotics

机译:使用特定抗生素对使用全部注射抗生素的人的患者的临床结果,具有干预和反馈的药剂师LED前瞻性审计的临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Prospective audit with intervention and feedback (PAF) and preauthorisation of antimicrobials are core strategies for antimicrobial stewardship (AS). PAF participants were expanded from patients using specific antibiotics to those using whole injectable antibiotics to evaluate clinical outcome. From January 2016 to December 2016, PAF was performed in patients using specific antibiotics (period 1) and from January 2017 to December 2017, PAF was performed in patients using whole injectable antibiotics (period 2). PAF was implemented for 5days every week by pharmacists involved in infectious diseases chemotherapy. In total, 11,571 and 11,103 patients used antibiotic injections during periods 1 and 2, respectively. No significant difference in mortality within 30days from the initial use of injection antibiotics was observed. The average duration of hospitalisation was significantly shorter during period 2 among patients using antibiotics; however, this was not significantly different from that of patients not receiving antibiotics. The average duration of therapy for intravenous antibiotics was significantly shorter during period 2 than during period 1. The ratio of methicillin-resistant Staphylococcus aureus (MRSA) to S. aureus was significantly low during period 2. The duration of intravenous antibiotic therapy for Escherichia coli bacteraemia during period 2 decreased significantly. De-escalation and appropriate antimicrobial treatment rates at specific doses during period 2 increased significantly. Expansion of patients eligible for PAF from patients using specific antibiotics to patients using whole injectable antibiotics shortened hospital stays, suppressed drug resistance, and promoted the appropriate use of antibiotics.
机译:具有干预和反馈(PAF)和抗菌药物的预期审计是抗微生物管理的核心策略(AS)。 PAF参与者从使用特定抗生素的患者扩展到使用全部注射抗生素来评估临床结果的人。从2016年1月到2016年12月,PAF于使用特异性抗生素(第1期)和2017年1月至2017年12月,PAF在使用全部注射抗生素(第2期)的患者中进行。 PAF每周由参与传染病化疗的药剂师实施5天。总共11,571和11,103名患者分别在1和2期间使用抗生素注射。观察到从注射抗生素初始使用的30天内死亡率没有显着差异。使用抗生素的患者的2期间,住院的平均持续时间明显短;然而,这与未接受抗生素的患者没有显着差异。静脉内抗生素的平均治疗持续时间在2期间比在1期间的时间内明显较短。期间甲氧西林抗性金黄色葡萄球菌(MRSA)与金黄色葡萄球菌的比例显着低。对大肠杆菌的静脉抗生素治疗的持续时间期间2期间的菌血症显着下降。在第2期间特定剂量的去升级和适当的抗微生物处理率显着增加。扩展患者有资格使用特定抗生素对使用全部注射抗生素缩短医院的患者的患者的患者,抑制耐药性,并促进适当使用抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号